23/01/2019

Anapharm Bioanalytics is proud to announce that it has been recently added to the List of Bioequivalence Centres Approved by GCC, Gulf Cooperation Council (United Arab Emirates, Bahrain, Kingdom of Saudi Arabia, Sultanate of Oman, Qatar, Kuwait and Republic of Yemen).

READ MORE

09/07/2018

Anapharm Bioanalytics is proud to announce that it has recently renewed its ANVISA (Brazil) certificate.
The renewed certification is valid until 11th June 2020.

READ MORE

02/07/2018

After the corresponding regulatory inspection Anapharm Bioanalytics has renewed once more its Certificate for Good Laboratory Practice Principles (GLP). The company is under GLP certification since its foundation. The present certificate is valid until June 2020.

READ MORE

15/06/2018

The presentation of our Bioanalytical Coordinator, Araceli Castillo, was focused on two trending topics on Bioanalysis: the final guidance on Bioanalytical Method Validation published by the US FDA on May 21st, 2018 and the progress on the new guideline ICH M10 for the harmonization of bioanalytical method validation.

READ MORE

17/12/2017

Anapharm Bioanalytics has successfully developed and validated a bioanalytical method for determination of Unconjugated Estradiol and Estrone in human plasma by LC-MS/MS.

READ MORE

15/05/2017

We are pleased to announce that as part of our rebranding strategy, our brand name has now changed from Anapharm Europe to Anapharm Bioanalytics.

READ MORE

28/04/2016

Anapharm Europe is proud to announce that it has successfully undergone its first US FDA inspection at its Barcelona based bioanalytical lab.

READ MORE

03/03/2016

Anapharm Europe is proud to announce that it has recently renewed its ANVISA (Brazil) certificate.

READ MORE

16/04/2015

Anapharm Europe has renewed its certification to offer the advantages of the French research tax credit (crédit d’impôt recherche) for period 2015 – 2019.

READ MORE